Clinical trial
Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva
NCT00395499 · Ohio State University, Other · Completed
Key facts
| NCT number | NCT00395499 |
|---|---|
| Title | Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva |
| Official title | Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva |
| Lead sponsor | Ohio State University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Patients Already Taking Risperidone for Clinical Indications |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 19 |
| Start date | May 1, 2001 |
| Completion | Apr 1, 2003 |
| First posted | Nov 3, 2006 |
| Last update posted | Jun 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: